Safety and efficacy of HRX215 in participants after minor and major liver resection - Clinical Trial
¿Cuál es el Propósito de este estudio?
If you join this study, you may receive a study medicine called HRX215 or a placebo, which looks the same but has no medicine in it. You will be placed into one of these two groups by chance, like picking a name from a hat. You have an equal chance of getting either one. If you are placed into a group by chance, neither you nor your study doctor will know which drug you are receiving.
Colorectal cancer that has spread to the liver
¿Quién puede participar en el Estudio?
¿Qué Implica?
This study is being done to learn if a new medicine called HRX215 is safe and helpful for people who need surgery to remove part of the liver because of colon cancer that has spread to the liver. Surgery to remove the liver tumor is the best treatment to help people live longer. For the surgery to work well, enough healthy liver must be left behind. HRX215 was created to help the liver heal and grow back faster after surgery.
Detalles del Estudio
